Evaluation of Sleep-EEG in Transgenic Mice

2017

PsychoGenics will carry out EEG readings of sleeping and awake ACE1 transgenic mice containing genetic variants identified by Genome-Wide Association Studies (GWAS) for their impact on Alzheimer’s disease risk. This research is being conducted in conjunction with Robert Vassar, Ph.D.’s project “Molecular and Cellular Mechanisms of ACE1 Variant in Alzheimer’s Disease.”

PsychoGenics Studies of Alternative Neurodegenerative Pathways Translational

Role of the Circulating Exerkine GPLD1 in Ameliorating Alzheimer’s Disease Pathology

Srdjan D. Antic, Riqiang Yan, | 2022

Alzheimer’s Disease Pathophysiology Alters the Level of Electrical and Chemical Synapse Coupling in the Network of GABAergic PV+ Interneurons Early in Disease Course

Sangram Sisodia, | 2022

Identifying the Sex-Specific Roles of the Gut Microbiome-Brain Axis in a Mouse Model of Amyloid Beta Amyloidosis

Evandro F. Fang, | 2022

Turning Up Mitophagy to Blunt Alzheimer’s Tau Pathologies

Andrew Yang, | 2022

Understanding How Human Brain Vascular Cells Mediate Genetic Risk for Alzheimer’s Disease

Sangram Sisodia, | 2022

Temporal Relationships Between Gut Dysbiosis and Microglia Cell Activation Following Antibiotic Treatment

Leonard Petrucelli, Casey Cook, | 2022

Evaluating TMEM106B Accumulation in Alzheimer’s Disease

Mathieu Bourdenx, Karen Duff, | 2022

Cellular Vulnerability to Aging in Alzheimer’s Disease

Evaluation of Sleep-EEG in Transgenic Mice

Funding to Date

Focus

Researchers

Related Content: